AU2002305940A1 - Neuroprotectants formulations and methods - Google Patents

Neuroprotectants formulations and methods

Info

Publication number
AU2002305940A1
AU2002305940A1 AU2002305940A AU2002305940A AU2002305940A1 AU 2002305940 A1 AU2002305940 A1 AU 2002305940A1 AU 2002305940 A AU2002305940 A AU 2002305940A AU 2002305940 A AU2002305940 A AU 2002305940A AU 2002305940 A1 AU2002305940 A1 AU 2002305940A1
Authority
AU
Australia
Prior art keywords
neuroprotectants
formulations
methods
neuroprotectants formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002305940A
Inventor
Glenn D. Frazer
David P. Hesson
Douglas Ross
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neuron Therapeutics Inc
Original Assignee
Neuron Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neuron Therapeutics Inc filed Critical Neuron Therapeutics Inc
Publication of AU2002305940A1 publication Critical patent/AU2002305940A1/en
Abandoned legal-status Critical Current

Links

AU2002305940A 2001-03-02 2002-02-28 Neuroprotectants formulations and methods Abandoned AU2002305940A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/798,880 2001-03-02

Publications (1)

Publication Number Publication Date
AU2002305940A1 true AU2002305940A1 (en) 2002-10-15

Family

ID=

Similar Documents

Publication Publication Date Title
AU2002357119A1 (en) Mitocidal compositions and methods
AU2003298738A1 (en) Liposomal formulations
AUPR510001A0 (en) Formulation and method
AU2001294808A1 (en) Catecholamine pharmaceutical compositions and methods
AU2002258221A1 (en) Medicinal composition
AU2003296369A1 (en) Imminoamines and preparation thereof
EP1370240A4 (en) Neuroprotectants formulations and methods
AU2002357748A1 (en) Osteopontin-related compositions and methods
AU2002345878A1 (en) Ilt3 and ilt4-related compositions and methods
AU2002345278A1 (en) Herbal formulation
AU2002345276A1 (en) Herbal formulation
AU2002338989A1 (en) Substituted C-furan-2-yl-methylamine and C-thiophen-2-yl-methylamine derivatives
AU2003263895A1 (en) Contraceptive methods and formulations
AU2002358719A1 (en) Agaricoglycerides and analogs
AUPR099200A0 (en) New formulation
AU2002354460A1 (en) Medicinal composition
AU2002359869A1 (en) Pak5-related compositions and methods
AU2002305940A1 (en) Neuroprotectants formulations and methods
AU2002307237A1 (en) Carboxybenzopyran derivatives and compositions
AU2002316356A1 (en) Liposomal formulations and related methods
AU2002329433A1 (en) Formulation
AU2002300836A1 (en) Solid Formulation
AUPR642301A0 (en) Formulation and method
AU2002256154A1 (en) Aminobenzopyran derivatives and compositions
AUPR354301A0 (en) Anthelmintic formulations and method